Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

Russell Nigel H.; Burnett Alan K.; Hills Robert K.; Betteridge Sophie; Dennis Michael; Dillon Richard; Grimwade David

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

【24h】

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

机译：减毒三氧化二砷和ATRA治疗新诊断和复发的急性早幼粒细胞白血病的NCRI AML17试验长期随访

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2016年第22期| 共6页
作者
Russell Nigel H.; Burnett Alan K.; Hills Robert K.; Betteridge Sophie; Dennis Michael; Dillon Richard; Grimwade David;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia [J] . Russell Nigel H., Burnett Alan K., Hills Robert K., Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：减毒三氧化二砷和ATRA治疗新诊断和复发的急性早幼粒细胞白血病的NCRI AML17试验长期随访
2. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia [J] . Lou Yinjun, Qian Wenbin, Meng Haitao, Hematological oncology . 2014 ,第1期

机译：小剂量全反式维甲酸加最小的化学诱导，再加上静脉三氧化二砷缓解后治疗在新诊断的急性早幼粒细胞白血病中的长期疗效
3. All-trans retinoic acid and arsenic combination therapy benefits low-to-intermediate-risk patients with newly diagnosed acute promyelocytic leukaemia: a long-term follow-up based on multivariate analysis [J] . Zhu Hongming, Hu Jiong, Li Xiaoyang, British Journal of Haematology . 2015 ,第2期

机译：全反式维甲酸和砷联合疗法使初诊急性早幼粒细胞白血病的中低危患者受益：基于多变量分析的长期随访
4. Arsenic Salvage Is Superior to Chemotherapy and Bone Marrow Transplantation for Relapsed Acute promyelocytic Leukemia: Ten Years of Experience from Hong Kong [C] . W.Y. Au, R. Liang, A.K.W. Lie, European Haematology Association . 2002

机译：砷救生优于化疗和骨髓移植复发急性突出细胞细胞白血病：来自香港的十年经验
5. Characterization of the novel arsenical darinaparsin (ZIO-101, S-dimethylarsino-glutathione) as a more potent inducer of oxidative stress and apoptosis than arsenic trioxide in acute promyelocytic leukemia. [D] . Kourelis, Maria. 2009

机译：在急性早幼粒细胞白血病中，新型砷化降火药（ZIO-101，S-二甲基ar-谷胱甘肽）比三氧化二砷更有效地诱导氧化应激和细胞凋亡。
6. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial [O] . Nigel Russell, Alan Burnett, Robert Hills, -1

机译：新诊断和复发的APL减毒三氧化二砷加ATRA治疗：AML17试验的长期随访
7. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial [O] . Nigel Russell, Alan Burnett, Robert Hills, 2018

机译：减毒的三氧化二砷加ATRA治疗，用于新诊断和复发APL：AML17试验的长期随访

Long Term Follow up from the NCRI AML17 Trial of Attenuated Arsenic Trioxide and ATRA Therapy for Newly Diagnosed and Relapsed Acute Promyelocytic Leukaemia

著录项

相似文献

相关主题

期刊订阅